Physician profile
Michele Gerber
NPI 1366467169
$1,504.89
in general payments reported to CMS, 2019-2025
21 companies · $40.04 in 2025
The $40.04 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $437 · 2020: $104 · 2021: $180 · 2022: $194 · 2023: $304 · 2024: $247 · 2025: $40.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $591.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $591.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $292.03 | 2023-2024 | Veozah |
| Abbvie INC. | $253.81 | 2019-2023 | |
| Myovant Sciences INC. | $144.04 | 2021-2022 | |
| Pfizer INC. | $142.91 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $89.38 | 2021-2023 | |
| Roche Diagnostics Corporation | $79.22 | 2019 | |
| Allergan, INC. | $71.44 | 2019 | |
| Merck Sharp & Dohme LLC | $64.60 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $54.25 | 2019-2025 | |
| Therapeuticsmd, INC. | $47.46 | 2019-2021 | |
| Amag Pharmaceuticals, INC. | $45.73 | 2019 | |
| Organon LLC | $38.28 | 2022-2023 | Nexplanon |
| Exeltis, USA INC. | $30.99 | 2024 | Slynd |
| Coopersurgical, INC. | $30.62 | 2024 | Paragard T 380a |
| Hologic Sales and Service, LLC | $20.23 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $18.47 | 2024 | Zurzuvae |
| Evofem Biosciences, INC. | $17.57 | 2023 | Phexxi |
| Millicent US INC | $17.50 | 2025 | Femring, Intrarosa |
| Mission Pharmacal Company | $17.39 | 2019 | |
| Minerva Surgical, INC | $14.50 | 2019 | |
| Duchesnay USA Incorporated | $14.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michele Gerber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.